WFM
ICPT

Wilmington Funds Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Wilmington Funds Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$464K Sell
1,961
-17
-0.9% -$4.48K 0.05% 380
2014
Q1 		$652K Buy
+1,978
New +$667K 0.07% 277

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wilmington Funds Management's ICPT Position: Q2 2014 in Review

Wilmington Funds Management reduced its Intercept Pharmaceuticals, Inc. (ICPT) stake by 0.86% in Q2 2014, selling an estimated $4.48K and leaving 1,961 shares worth $464K. The position accounts for 0.05% of the portfolio, ranked #380.

Wilmington Funds Management first reported a position in ICPT in Q1 2014 and has held it in 2 quarters since. The position peaked at $652K in Q1 2014. 167 funds tracked by Wall St. Rank hold ICPT as of Q2 2014.

  • Wilmington Funds Management held 1,961 shares of Intercept Pharmaceuticals, Inc. worth $464K as of Q2 2014.
  • Wilmington Funds Management sold 17 Intercept Pharmaceuticals, Inc. shares in Q2 2014, an estimated $4.48K.
  • Intercept Pharmaceuticals, Inc. made up 0.05% of Wilmington Funds Management's portfolio in Q2 2014, its #380 holding.
  • Wilmington Funds Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and has held it in 2 quarters since.
  • Wilmington Funds Management's Intercept Pharmaceuticals, Inc. position peaked at $652K in Q1 2014.
  • 167 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.